Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 1
1989 2
1990 3
1991 4
1992 3
1993 8
1994 6
1995 17
1996 16
1997 13
1998 19
1999 22
2000 23
2001 29
2002 32
2003 24
2004 37
2005 38
2006 24
2007 28
2008 30
2009 27
2010 33
2011 37
2012 28
2013 38
2014 39
2015 31
2016 36
2017 40
2018 38
2019 33
2020 39
2021 46
2022 39
2023 33
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

818 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Transplant-Related Disorder"
Page 1
Idiopathic myelofibrosis.
Barosi G, Hoffman R. Barosi G, et al. Semin Hematol. 2005 Oct;42(4):248-58. doi: 10.1053/j.seminhematol.2005.05.018. Semin Hematol. 2005. PMID: 16210038 Review.
The use of fully myeloablative conditioning regimens, with or without total body irradiation, is associated with a high transplant-related mortality rate (27% to 48%), especially in patients with advanced disease and in the elderly. The use of reduced intensi …
The use of fully myeloablative conditioning regimens, with or without total body irradiation, is associated with a high transplant- …
Acute Graft-versus-Host Disease: An Update on New Treatment Options.
Patel DA, Crain M, Pusic I, Schroeder MA. Patel DA, et al. Drugs. 2023 Jul;83(10):893-907. doi: 10.1007/s40265-023-01889-2. Epub 2023 May 29. Drugs. 2023. PMID: 37247105 Review.
Acute graft-versus-host disease (GVHD) occurs in approximately 50% of patients and remains a primary driver of non-relapse and transplant-related mortality. ...Modern therapies for treatment of the disease include JAK/STAT pathway inhibitors, which are …
Acute graft-versus-host disease (GVHD) occurs in approximately 50% of patients and remains a primary driver of non-relapse and tra …
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
McKenna M, Epperla N, Ghobadi A, Liu J, Lazaryan A, Ibrahim U, Jacobson CA, Naik SG, Nastoupil L, Chowdhury SM, Voorhees TJ, Jacobs MT, Farooq U, Osman K, Olszewski AJ, Ahmed S, Evens AM. McKenna M, et al. Br J Haematol. 2023 Jul;202(2):248-255. doi: 10.1111/bjh.18828. Epub 2023 May 2. Br J Haematol. 2023. PMID: 37129856
The use of CD19 chimeric antigen receptor T-cell (CAR-T) therapy for relapsed/refractory solid organ transplantation (SOT)-related post-transplant lymphoproliferative disorder (PTLD) is not well studied. We conducted a multicentre, retrospective analysis of adults with rel …
The use of CD19 chimeric antigen receptor T-cell (CAR-T) therapy for relapsed/refractory solid organ transplantation (SOT)-related post-tran …
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.
Sill H, Olipitz W, Zebisch A, Schulz E, Wölfler A. Sill H, et al. Br J Pharmacol. 2011 Feb;162(4):792-805. doi: 10.1111/j.1476-5381.2010.01100.x. Br J Pharmacol. 2011. PMID: 21039422 Free PMC article. Review.
Therapy-related myeloid neoplasms (t-MNs) are serious long-term consequences of cytotoxic treatments for an antecedent disorder. t-MNs are observed after ionizing radiation as well as conventional chemotherapy including alkylating agents, topoisomerase-II-inhibitors …
Therapy-related myeloid neoplasms (t-MNs) are serious long-term consequences of cytotoxic treatments for an antecedent disorder. t-MN …
Cardiovascular risk in renal transplant recipients.
Devine PA, Courtney AE, Maxwell AP. Devine PA, et al. J Nephrol. 2019 Jun;32(3):389-399. doi: 10.1007/s40620-018-0549-4. Epub 2018 Nov 7. J Nephrol. 2019. PMID: 30406606 Free PMC article. Review.
Successful kidney transplantation offers patients with end-stage renal disease the greatest likelihood of survival. However, cardiovascular disease poses a major threat to both graft and patient survival in this cohort. ...Additional transplant-specific factors such …
Successful kidney transplantation offers patients with end-stage renal disease the greatest likelihood of survival. However, cardiova …
Outcomes in liver transplantation: does sex matter?
Sarkar M, Watt KD, Terrault N, Berenguer M. Sarkar M, et al. J Hepatol. 2015 Apr;62(4):946-55. doi: 10.1016/j.jhep.2014.11.023. Epub 2014 Nov 27. J Hepatol. 2015. PMID: 25433162 Free PMC article. Review.
A growing literature has highlighted important differences in transplant-related outcomes between men and women. In the United States there are fewer women than men on the liver transplant waitlist and women are two times less likely to receive a deceased or living- …
A growing literature has highlighted important differences in transplant-related outcomes between men and women. In the United …
The autoimmune origin of atherosclerosis.
Blasi C. Blasi C. Atherosclerosis. 2008 Nov;201(1):17-32. doi: 10.1016/j.atherosclerosis.2008.05.025. Epub 2008 May 23. Atherosclerosis. 2008. PMID: 18585722 Review.
Atherosclerosis is a chronic inflammatory disease. Many studies and observations suggest that it could be caused by an immune reaction against autoantigens at the endothelial level, the most relevant of which are oxidized LDL and heat shock proteins (HSP) 60/65. ... …
Atherosclerosis is a chronic inflammatory disease. Many studies and observations suggest that it could be caused by an immune …
Analysis of survival outcomes in haematopoietic cell transplant studies: Pitfalls and solutions.
de Wreede LC, Schetelig J, Putter H. de Wreede LC, et al. Bone Marrow Transplant. 2022 Sep;57(9):1428-1434. doi: 10.1038/s41409-022-01740-4. Epub 2022 Jun 27. Bone Marrow Transplant. 2022. PMID: 35760893 Review.
The endpoint is clear with rare exception, the subject is either alive or dead. Compare this to other less well defined transplant-related outcomes such as who has acute graft-versus-host disease (GvHD) and of what grade or what is the cause of interstitial p …
The endpoint is clear with rare exception, the subject is either alive or dead. Compare this to other less well defined transplant- …
New approaches to the treatment of older adults with acute lymphoblastic leukemia.
Schwartz M, Wieduwilt MJ. Schwartz M, et al. Semin Hematol. 2020 Jul;57(3):122-129. doi: 10.1053/j.seminhematol.2020.09.001. Epub 2020 Sep 5. Semin Hematol. 2020. PMID: 33256901 Review.
Advances in minimal residual disease detection have helped to effectively stratify adults in complete response in terms of relapse risk and predicted relative benefit for allogeneic hematopoietic cell transplant. For older adults with ALL in complete response at hig …
Advances in minimal residual disease detection have helped to effectively stratify adults in complete response in terms of relapse ri …
The role of microbiota in allogeneic hematopoietic stem cell transplantation.
Chang CC, Hayase E, Jenq RR. Chang CC, et al. Expert Opin Biol Ther. 2021 Aug;21(8):1121-1131. doi: 10.1080/14712598.2021.1872541. Epub 2021 Jan 18. Expert Opin Biol Ther. 2021. PMID: 33412949 Free PMC article. Review.
AREAS COVERED: This article reviews the current knowledge of the microbiota's impact on allo-HSCT outcomes, including effects of microbiota-derived metabolites, and crosstalk between commensals and the allogeneic immune response. This article also summarizes the effects of HSCT a …
AREAS COVERED: This article reviews the current knowledge of the microbiota's impact on allo-HSCT outcomes, including effects of microbiota- …
818 results